03/29/2024
5:19 AM | Elevai Labs (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
9:57 AM | Braeden Lichti (Filed by)
Elevai Labs (Subject)
| Form SC 13D | |
02/16/2024
8:50 PM | Braeden Lichti (Reporting)
Elevai Labs (Issuer)
| Form 3/A | |
02/16/2024
8:51 PM | BWL Investments Ltd. (Reporting)
Elevai Labs (Issuer)
| Form 3/A | |
02/14/2024
8:30 AM | Elevai Labs (Subject)
Plews Jordan R. (Filed by)
| Form SC 13G | |
02/14/2024
8:30 AM | Elevai Labs (Subject)
JP Bio Consulting LLC (Filed by)
| Form SC 13G | |
02/14/2024
8:30 AM | Elevai Labs (Subject)
Hatem Abou-Sayed MD MBA FACS, a Professional Medical Corp (Filed by)
| Form SC 13G | |
|
02/14/2024
8:30 AM | Abou-Sayed Hatem (Filed by)
Elevai Labs (Subject)
| Form SC 13G | |
02/01/2024
8:55 PM | Braeden Lichti (Reporting)
Elevai Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/01/2024
8:44 PM | BWL Investments Ltd. (Reporting)
Elevai Labs (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
7:20 PM | BWL Investments Ltd. (Reporting)
Elevai Labs (Issuer)
| Form 3/A | |
01/22/2024
11:01 AM | Elevai Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:50 PM | Elevai Labs (Issuer)
Kraneiss Chris (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:53 PM | Elevai Labs (Issuer)
Muilenburg Crystal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:54 PM | Elevai Labs (Issuer)
JP Bio Consulting LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:55 PM | Elevai Labs (Issuer)
Plews Jordan R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:45 PM | BWL Investments Ltd. (Reporting)
Elevai Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:47 PM | Elevai Labs (Issuer)
GB Capital Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:50 PM | Bensler Graydon (Reporting)
Elevai Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:51 PM | Elevai Labs (Issuer)
Hatem Abou-Sayed MD MBA FACS, a Professional Medical Corp (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:53 PM | Abou-Sayed Hatem (Reporting)
Elevai Labs (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
2:54 PM | Elevai Labs (Issuer)
Parry Jeffrey (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
8:00 AM | Elevai Labs (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/24/2023
4:08 PM | Elevai Labs (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
11:10 AM | Elevai Labs (Filer)
| Form 424B4 | |
11/20/2023
3:18 PM | Elevai Labs (Filer)
| Form CERT | |
11/20/2023
8:30 AM | Elevai Labs (Filer)
| Form 8-A12B | |
11/13/2023
11:15 PM | Elevai Labs (Filer)
| Form EFFECT | |
11/09/2023
12:01 PM | Elevai Labs (Filer)
| Form S-1/A | |
09/22/2023
3:27 PM | Elevai Labs (Filer)
| Form D
Notice of Exempt Offering of Securities | |
